Clinical Trials Directory

Trials / Terminated

TerminatedNCT00403234

Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study to Evaluate the Analgesic Efficacy of BTDS on Postoperative Pain During Rehabilitation Following Total Knee Arthroplasty

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Purdue Pharma LP · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The objectives in this study are to evaluate: (1) efficacy of buprenorphine transdermal system (BTDS, Butrans™) on postoperative pain following total knee replacement surgery; (2) the impact of BTDS on functional rehabilitative measures after total knee replacement surgery; and 3) the safety of BTDS after total knee replacement surgery. The double-blind treatment period is for 28 days during which time supplemental analgesic medication will be provided to all subjects in addition to study drug. Purdue Pharma L.P. terminated the trial early due to administrative reasons not related to efficacy or safety. The focus of this study became safety evaluations.

Detailed description

Buprenorphine is a synthetic opioid analgesic with over 25 years of international clinical experience indicating it to be safe and effective in a variety of therapeutic situations for the relief of moderate to severe pain.

Conditions

Interventions

TypeNameDescription
DRUGBuprenorphine transdermal patchBuprenorphine transdermal patch 10 mcg/h applied for 7-day wear.
DRUGBuprenorphine transdermal patchBuprenorphine transdermal patch 20 mcg/h applied for 7-day wear.
DRUGBuprenorphine transdermal patchBuprenorphine transdermal patches 10 mcg/h and 20 mcg/h (total of 30 mcg/h) applied for 7-day wear.
DRUGPlacebo BTDSPlacebo to match BTDS transdermal 10 and 20 patches applied for 7-day wear.

Timeline

Start date
2006-11-01
Primary completion
2007-04-01
Completion
2007-08-01
First posted
2006-11-23
Last updated
2012-09-03
Results posted
2010-09-21

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00403234. Inclusion in this directory is not an endorsement.